Pembrolizumab Combined With Either Docetaxel or Gemcitabine in Patients With Advanced or Metastatic Platinum-Refractory Urothelial Cancer: Results From a Phase I Study
| Autor: | Parikh, Mamta, Pan, Chong-Xian, Beckett, Laurel A., Li, Yueju, Robles, Daniel A., Aujla, Pawandeep K., Lara, Primo N., Jr. |
|---|---|
| Zdroj: | In Clinical Genitourinary Cancer December 2018 16(6):421-428 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect